Current and historical daily PE Ratio for Accelerated Pharma Inc (
) from 2016 to May 17 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Accelerated Pharma stock (ACCP) PE ratio as of May 17 2024 is 0.
More Details
Accelerated Pharma Inc (ACCP) PE Ratio (TTM) Chart
Accelerated Pharma Inc (ACCP) PE Ratio (TTM) Historical Data
View and export this data going back to 2016. Start your Free Trial
Total 0
- 1
| Accelerated Pharma PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
Accelerated Pharma Inc (ACCP) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Accelerated Pharma Inc
NAICS : 325412
SIC : 2834
ISIN : US00434Y1010
Description
Accelerated Pharma Inc, is a Delaware corporation organized on May 12, 2014. It is a biopharmaceutical company focused on utilizing its genomic technology to enhance the development and commercialization of pharmaceutical products. Its lead product candidate is Picoplatin, a new generation platinum-based cancer therapy that has the potential for use in different formulations, as a single agent or in combination with other anti-cancer agents, to treat multiple cancer indications.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers